BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $204,000 | -95.8% | 158 | -96.6% | 0.00% | – |
| Q3 2019 | $4,809,000 | -38.2% | 4,580 | 0.0% | 0.00% | – |
| Q2 2019 | $7,786,000 | -81.6% | 4,580 | -63.6% | 0.00% | – |
| Q1 2019 | $42,351,000 | +106.5% | 12,567 | +78.9% | 0.00% | – |
| Q4 2018 | $20,507,000 | -80.4% | 7,023 | -58.6% | 0.00% | – |
| Q3 2018 | $104,406,000 | -16.5% | 16,949 | 0.0% | 0.00% | – |
| Q2 2018 | $125,084,000 | +194.1% | 16,949 | +161.4% | 0.00% | – |
| Q1 2018 | $42,528,000 | -18.6% | 6,483 | +4.4% | 0.00% | – |
| Q4 2017 | $52,243,000 | +72.1% | 6,212 | +136.3% | 0.00% | – |
| Q3 2017 | $30,365,000 | -1.1% | 2,629 | 0.0% | 0.00% | – |
| Q2 2017 | $30,707,000 | +24865.0% | 2,629 | +26190.0% | 0.00% | – |
| Q1 2017 | $123,000 | -97.4% | 10 | -97.2% | 0.00% | – |
| Q4 2016 | $4,808,000 | -83.4% | 353 | -75.7% | 0.00% | – |
| Q3 2016 | $28,935,000 | +163.3% | 1,454 | +71.5% | 0.00% | – |
| Q2 2016 | $10,990,000 | -67.1% | 848 | -48.6% | 0.00% | – |
| Q4 2015 | $33,446,000 | +23.2% | 1,650 | -11.7% | 0.00% | – |
| Q3 2015 | $27,157,000 | +85.6% | 1,869 | +171.7% | 0.00% | – |
| Q2 2015 | $14,634,000 | +215.8% | 688 | +244.0% | 0.00% | – |
| Q1 2015 | $4,634,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 918,000 | $11,328,000 | 4.35% |
| EMORY UNIVERSITY | 164,607 | $2,031,000 | 1.92% |
| Monashee Investment Management LLC | 160,000 | $1,974,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 210,260 | $2,595,000 | 0.65% |
| CORRADO ADVISORS, LLC | 83,622 | $1,032,000 | 0.59% |
| Foresite Capital Management II, LLC | 105,000 | $1,296,000 | 0.56% |
| Baker Brothers Advisors | 5,032,313 | $62,099,000 | 0.51% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $2,468,000 | 0.48% |
| Clearline Capital LP | 55,200 | $681,000 | 0.32% |
| LMR Partners LLP | 270,594 | $3,339,000 | 0.32% |